Natural autoantibodies in the physiology and pathophysiology of the immune system

Journal of Autoimmunity

Volumn 41, Issue , 2013, Pages 46-49

  Avrameas, Stratis ^a,b   Selmi, Carlo ^c,d  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b HELLENIC PASTEUR INSTITUTE   (Greece)

^c HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Immune network; Natural autoantibodies; Physiological autoimmunity; Self recognition

Indexed keywords

ANTIGEN; AUTOANTIBODY; CYTOKINE; IMMUNOGLOBULIN; PROTEIN;

ADAPTIVE IMMUNITY; AUTOIMMUNE DISEASE; AUTOIMMUNITY; B LYMPHOCYTE; HUMAN; IMMUNE SYSTEM; IMMUNOLOGICAL MEMORY; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

ANIMALS; ANTIGENS; AUTOANTIBODIES; AUTOANTIGENS; B-LYMPHOCYTES; CLONAL SELECTION, ANTIGEN-MEDIATED; HUMANS; IMMUNE SYSTEM; MODELS, IMMUNOLOGICAL;

EID: 84875961146     PISSN: 08968411     EISSN: 10959157     Source Type: Journal    
DOI: 10.1016/j.jaut.2013.01.006     Document Type: Review

References (47)

1. Avrameas S. Natural autoantibodies: from 'horror autotoxicus' to 'gnothi seauton'. Immunol Today 1991, 12:154-159.
2. Cohen I.R. The cognitive paradigm and the immunological homunculus. Immunol Today 1992, 13:490-494.
3. Coutinho A., Kazatchkine M.D., Avrameas S. Natural autoantibodies. Curr Opin Immunol 1995, 7:812-818.
4. Notkins A.L. Polyreactivity of antibody molecules. Trends Immunol 2004, 25:174-179.
5. Cohen I.R. Biomarkers, self-antigens and the immunological homunculus. J Autoimmun 2007, 29:246-249.
6. Cerny-Provaznik R., Kloosterman T., Verkerk D., van Mourik P., Reboul M., Frangoulis B., et al. Anti-MHC immunity detected prior to intentional alloimmunization. IV. Natural monoclonal H-2-specific antibodies. J Immunogenet 1986, 13:287-297.
7. Spalter S.H., Kaveri S.V., Bonnin E., Mani J.C., Cartron J.P., Kazatchkine M.D. Normal human serum contains natural antibodies reactive with autologous ABO blood group antigens. Blood 1999, 93:4418-4424.
8. Ravindranath M.H., Kaneku H., El-Awar N., Morales-Buenrostro L.E., Terasaki P.I. Antibodies to HLA-E in nonalloimmunized males: pattern of HLA-Ia reactivity of anti-HLA-E-positive sera. J Immunol 2010, 185:1935-1948.
9. Baumgarth N. The double life of a B-1 cell: self-reactivity selects for protective effector functions. Nat Rev Immunol 2011, 11:34-46.
10. Tiller T., Tsuiji M., Yurasov S., Velinzon K., Nussenzweig M.C., Wardemann H. Autoreactivity in human IgG+ memory B cells. Immunity 2007, 26:205-213.
11. Mouquet H., Scheid J.F., Zoller M.J., Krogsgaard M., Ott R.G., Shukair S., et al. Polyreactivity increases the apparent affinity of anti-HIV antibodies by heteroligation. Nature 2010, 467:591-595.
12. Liao H.X., Chen X., Munshaw S., Zhang R., Marshall D.J., Vandergrift N., et al. Initial antibodies binding to HIV-1 gp41 in acutely infected subjects are polyreactive and highly mutated. J Exp Med 2011, 208:2237-2249.
13. Tumas-Brundage K.M., Notidis E., Heltemes L., Zhang X., Wysocki L.J., Manser T. Predominance of a novel splenic B cell population in mice expressing a transgene that encodes multireactive antibodies: support for additional heterogeneity of the B cell compartment. Int Immunol 2001, 13:475-484.
14. Roy B., Shukla S., Lyszkiewicz M., Krey M., Viegas N., Duber S., et al. Somatic hypermutation in peritoneal B1b cells. Mol Immunol 2009, 46:1613-1619.
15. Miller F.W., Alfredsson L., Costenbader K.H., Kamen D.L., Nelson L.M., Norris J.M., et al. Epidemiology of environmental exposures and human autoimmune diseases: findings from a National Institute of Environmental Health Sciences Expert Panel Workshop. J Autoimmun 2012, 39:259-271.
16. Selmi C., Leung P.S., Sherr D.H., Diaz M., Nyland J.F., Monestier M., et al. Mechanisms of environmental influence on human autoimmunity: a National Institute Of Environmental Health Sciences Expert Panel Workshop. J Autoimmun 2012, 39:272-284.
17. Miller F.W., Pollard K.M., Parks C.G., Germolec D.R., Leung P.S., Selmi C., et al. Criteria for environmentally associated autoimmune diseases. J Autoimmun 2012, 39:253-258.
18. Germolec D., Kono D.H., Pfau J.C., Pollard K.M. Animal models used to examine the role of the environment in the development of autoimmune disease: findings from an NIEHS Expert Panel Workshop. J Autoimmun 2012, 39:285-293.
19. Shoenfeld Y., Toubi E. Protective autoantibodies: role in homeostasis, clinical importance, and therapeutic potential. Arthritis Rheum 2005, 52:2599-2606.
20. Avrameas S., Ternynck T., Tsonis I.A., Lymberi P. Naturally occurring B-cell autoreactivity: a critical overview. J Autoimmun 2007, 29:213-218.
21. Zhou Z.H., Tzioufas A.G., Notkins A.L. Properties and function of polyreactive antibodies and polyreactive antigen-binding B cells. J Autoimmun 2007, 29:219-228.
22. Lutz H.U. Homeostatic roles of naturally occurring antibodies: an overview. J Autoimmun 2007, 29:287-294.
23. Lutz H.U., Binder C.J., Kaveri S. Naturally occurring auto-antibodies in homeostasis and disease. Trends Immunol 2009, 30:43-51.
24. Ehrenstein M.R., Notley C.A. The importance of natural IgM: scavenger, protector and regulator. Nat Rev Immunol 2010, 10:778-786.
25. Zhou Z.H., Zhang Y., Hu Y.F., Wahl L.M., Cisar J.O., Notkins A.L. The broad antibacterial activity of the natural antibody repertoire is due to polyreactive antibodies. Cell Host Microbe 2007, 1:51-61.
26. Matter M.S., Ochsenbein A.F. Natural antibodies target virus-antibody complexes to organized lymphoid tissue. Autoimmun Rev 2008, 7:480-486.
27. Zhou T., Georgiev I., Wu X., Yang Z.Y., Dai K., Finzi A., et al. Structural basis for broad and potent neutralization of HIV-1 by antibody VRC01. Science 2010, 329:811-817.
28. Miller Y.I., Choi S.H., Wiesner P., Fang L., Harkewicz R., Hartvigsen K., et al. Oxidation-specific epitopes are danger-associated molecular patterns recognized by pattern recognition receptors of innate immunity. Circ Res 2011, 108:235-248.
29. Chen Y., Khanna S., Goodyear C.S., Park Y.B., Raz E., Thiel S., et al. Regulation of dendritic cells and macrophages by an anti-apoptotic cell natural antibody that suppresses TLR responses and inhibits inflammatory arthritis. J Immunol 2009, 183:1346-1359.
30. Toubi E., Shoenfeld Y. Protective autoimmunity in cancer (review). Oncol Rep 2007, 17:245-251.
31. Vollmers H.P., Brandlein S. Natural antibodies and cancer. Nat Biotechnol 2009, 25:294-298.
32. de Faire U., Frostegard J. Natural antibodies against phosphorylcholine in cardiovascular disease. Ann N Y Acad Sci 2009, 1173:292-300.
33. Neff F., Wei X., Nolker C., Bacher M., Du Y., Dodel R. Immunotherapy and naturally occurring autoantibodies in neurodegenerative disorders. Autoimmun Rev 2008, 7:501-507.
34. Rodriguez M., Warrington A.E., Pease L.R. Invited article: human natural autoantibodies in the treatment of neurologic disease. Neurology 2009, 72:1269-1276.
35. Kaveri S.V. Intravenous immunoglobulin: exploiting the potential of natural antibodies. Autoimmun Rev 2012, 11:792-794.
36. Grabar P. Some considerations of the problem of auto-antibody formation. Tex Rep Biol Med 1965, 23(Suppl. 1):278-284.
37. Zelenay S., Moraes Fontes M.F., Fesel C., Demengeot J., Coutinho A. Physiopathology of natural auto-antibodies: the case for regulation. J Autoimmun 2007, 29:229-235.
38. Merbl Y., Zucker-Toledano M., Quintana F.J., Cohen I.R. Newborn humans manifest autoantibodies to defined self molecules detected by antigen microarray informatics. J Clin Invest 2007, 117:712-718.
39. Mietzner B., Tsuiji M., Scheid J., Velinzon K., Tiller T., Abraham K., et al. Autoreactive IgG memory antibodies in patients with systemic lupus erythematosus arise from nonreactive and polyreactive precursors. Proc Natl Acad Sci U S A 2008, 105:9727-9732.
40. Zhang J., Jacobi A.M., Wang T., Berlin R., Volpe B.T., Diamond B. Polyreactive autoantibodies in systemic lupus erythematosus have pathogenic potential. J Autoimmun 2009, 33:270-274.
41. Bogdanos D.P., Smyk D.S., Rigopoulou E.I., Mytilinaiou M.G., Heneghan M.A., Selmi C., et al. Twin studies in autoimmune disease: genetics, gender and environment. J Autoimmun 2012, 38:J156-J169.
42. Selmi C., Lu Q., Humble M.C. Heritability versus the role of the environment in autoimmunity. J Autoimmun 2012, 39:249-252.
43. Danieli M.G., Pettinari L., Moretti R., Logullo F., Gabrielli A. Subcutaneous immunoglobulin in polymyositis and dermatomyositis: a novel application. Autoimmun Rev 2011, 10:144-149.
44. Li C.R., Deiro M.F., Godebu E., Bradley L.M. IL-7 uniquely maintains FoxP3(+) adaptive Treg cells that reverse diabetes in NOD mice via integrin-beta7-dependent localization. J Autoimmun 2011, 37:217-227.
45. Hickman-Brecks C.L., Racz J.L., Meyer D.M., LaBranche T.P., Allen P.M. Th17 cells can provide B cell help in autoantibody induced arthritis. J Autoimmun 2011, 36:65-75.
46. Sharma R., Sung S.S., Ju C.Y., Deshmukh U.S., Fu S.M., Ju S.T. Regulatory T-Cell (Treg) hybridoma as a novel tool to study Foxp3 regulation and Treg fate. J Autoimmun 2011, 37:113-121.
47. Alessandri C., Conti F., Pendolino M., Mancini R., Valesini G. New autoantigens in the antiphospholipid syndrome. Autoimmun Rev 2011, 10:609-616.